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To investigate the usefulness of melanin macroglob-
ules (MMG) as a cellular marker for neurofibromatosis, 
their density was quantified in biopsies of cafe-au-lait 
spots (macules) (CALM) from 22 patients with von Reck-
linghausen's neurofibromatosis, 6 patients with bilat-
eral acoustic neurofibromatosis, and 19 controls. The 
density of MMG was significantly higher in biopsies of 
the CALM of patients with von Recklinghausen's neu-
rofibromatosis than in patients with bilateral acoustic 
neurofibromatosis (p < .01) or controls (p < .0008). The 
mode of acquisition of von Recklinghausen's neurofibro-
matosis (inherited vs new mutation) was not related to 
the density of MMG. On light microscopy, 14/22 (64%) 
patients with von Recklinghausen's neurofibromatosis 
had 11 or more MMG per 5 high-power fields. In con-
trast, none of the other two groups had more than 10 
MMG per 5 high-power fields. 
Neurofibromatosis (NF) is a relatively common (1/3200 to 
1/7800 births), highly penetrant (greater than 90%), autosomal 
dominant disorder with variable expression [1 - 4]. NF is asso-
ciated with dysplasia or neoplasia of various cells of neural 
crest origin [5]. The most common abnormalit ies are present 
in t he melanocytes of cafe-au-lait spots (macules) (CALM) and 
in the Schwann cells of cutaneous neurofibromas, bilateral 
acoustic neuromas, plexiform neurofibromas, and other 
Schwannomas. 
Currently the diagnosis of NF is made by documenting a 
group of clinica l stigmata which are commonly present in NF 
patients but which are absent or less common in t he remaining 
population. Cri te ri a to diagnose NF include the presence of 6 
or more CALM (15 mm or larger) in adults or 5 or more CALM 
(5 mm or larger) in children, or the presence of 3 or more 
cutaneous neurofibromas or plexiform neurofibromas [1 ,2,6]. 
O t her features include axillary or in tertriginous freckling and 
pigmented iri s hamartomas (Lisch nodules) [3,7] . Many pa-
tients exhibit all of these stigmata; however, NF is a variably 
expressed disorder and some patients may manifest on ly a few 
of these abnormali t ies. 
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Bilateral acoustic neurofib romatosis (BANF), a lternatively 
called central neurofibromatosis or NF with bilateral acoustic 
neuromas, appears to be a genetic entity distinct from classical 
von Recklinghausen 's neurofibromatosis (VRNF) and may be 
due to a defect of a different gene or a separate a llele of the 
same gene [7- 9]. BANF is an autosomal dominant disorder 
associated with bilateral acoustic neuromas, multiple spinal 
neurofibromas, and spinal and cranial meningiomas. The nu-
merous central nervous system abnormalities contrast with the 
few cutaneous manifestations. CALM, cutaneous neurofibro-
mas, or plexiform neurofibromas may be absent or few in 
number [7- 9]. Because of the presence of t hese two distinct 
forms of NF (VRNF and BANF) and the highly variable 
expression of each form , diagnosis on the basis of clinical 
stigmata alone is at t imes difficul t and attempts have been 
made to find a cellular marker for NF [10] . In t his regard , gian t 
pigment particles which are ca lled melanin macroglobules 
(MMG) and which were formerly termed macromelanosomes, 
may be detected in biopsies of CALM and have been suggested 
as one possible cellular marker of NF (11 ,12]. 
Other investigators have noted MMG in normal skin , in 
Albright's syndrome, and in pigmentary disorders other than 
CALM, suggesting that their presence is not pathognomonic of 
NF [13,14] . This study was undertaken to quantitate the num -
ber of MMG in CALM and in normal skin to determine t he 
usefulness of MMG as a marker for the diagnosis of NF or as 
a potential phenotypic marker for investigations into t he 
expression of the NF gene(s) . 
MATERIALS AND METHODS 
Most YRNF and BANF patients were either self-re ferred or phys i-
cian -referred t.o the Massachusetts Genera l Hospital Neurofibromato-
sis Clinic, or were entered through the Neurosurgery Service when 
hospita li zed for evaluation of t heir disorder. Parents and relatives of 
these patients were a lso requested to enter this study at t.he t.ime of 
fa mily evaluation . No rmal co nt rols were eit her volunteers or patients 
with other unrelated diso rders in whom a CAL M was noted on rout ine 
examination. All patients received an iris s li t -la mp exa mination a nd a 
t horough dermatologic exa mination in room light a nd wt th a Woods 
la mp. At t he request of t.he Huma n Studies Committee, perso ns 15 
yea rs of age or younger were not subjected to skin biopsy fo~ this s tudy. 
After obta ining informed co nsent., a s kin biopsy was performed on a 
CALM, if present, as well as on adjacent. normally p1gmented skill . For 
cosmetic reasons the chose n site was the !la nk or upper buttock 
wheneve r possibl ~. After s terile s kin prepa ration , 1% lidocaine- H CI 
was instilled a nd a 4-mm punch biopsy or a Thiersch bi opsy was 
obta ined. The specimens were divided a nd prepa red for split dopa 
reaction a nd for electron microscopy. 
For the split dopa react ion, the s kin was incubated in 2 N NaB r for 
2 h at 37•c t.o achieve separation of t he epidermis. This was washed 
with 0. 1 M phosphate buffer (pH 7.4), a nd incubated at 37"C in 0.1% 
L-dopa (3,4-dihydroxyphenyla la nine) in t he phosphate buffer. Two 
solu tion chanues were used durin " a 4- t.o 5- h period. The tissue was 
then incubated for 5 min in 10% f; nnalin a nd dehydra ted with sequen-
tia l 5- min incubations in etha nol 50%, 70 %, 80%, 90%, a nd 10 min at 
100 ,;,_ Aft.er 5 min in xylene, the epidermis was mounted on a glass 
slide wit h Permount (Fisher Scient ifi , Co., Fairlawn, New J ersey) for 
ana lys is. 
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The spliL dopa specimens were init ia lly surveyed by ligh t microscopy. 
E ach specimen was reviewed by 2 exa miners us ing a Zeiss mic roscope 
wi l h a 40X objec tive a nd a 12.5X eyepiece, giv ing a hi gh-power a rea of 
0. 159 mm2. If pi gmented gra nu les larger t ha n 1 lim were noted , the 
spec imen was qua nti!ied. MMG were not evenly distribu ted t hroughout 
t he specimens; the refore t he highest-dens ity a rea was se lected , a nd 1 
ce ntra l and 4 adjacen t high-power fi elds (HPF) were counted. This 
sco re is represen ted in the va rious tables as MMG per 5 HPF. Each 
s lide was scored by 2 exa miners lacking kn owledge of the source of t he 
specimen . A 2-s ided Wilcoxon ra nk test was used to determine whethe r 
TABLE I. M elanin ma.croglobu.les (MMG) in. controls 
CALM MMG 
Case# Catel(ory Age Sex 
Number Size (mm) CALM Normal skin 
1 Voluntee r 57 F 12 :J 4 
2 Volunteer 33 M l 170 0 1 
;) Volunteer 24 M 2 15; 37 () 0 
Voluntee r 27 M 1 35 1 0 
!i Voluntee r :Jo M 15 1 0 
(i Voluntee r 25 F 18 1 0 
7 Voluntee r 2!i F 30 I. 0 
8 Voluntee r 28 F 2 10; 30 0 NO 
9 Vo lun tee r 33 F J 8 0 0 
10 Spouse VRN F 51 F 2 G; 12 0 0 
11 Spouse VRNF 53 M 1 18 0 0 
12 Parent VRNF 37 M () NA NA 0 
J:l Parent VRN F 3:3 F I 30 0 0 
14 Parent VHNF 30 F l 70 0 0 
] .'j Parent VH NF 32 M () N A NA 0 
] (i Parent VRN F 48 F 2 75: 28 4 0 
17 Parent VRNF 33 F 0 NA NA 1 
18 Son VRNF 20 M I 2 0 0 
19 Son VRNF 24 M 1 128 0 0 
20 Parent BA NF 50 F 1 8 1 2 
21 Parent BANF !) 1 F 0 NA NA 0 
22 Parent BANF 63 M 0 NA NA 0 
23 Parent BANF 60 F 0 NA NA 0 
24 Sister BANF 27 F 1 10 1 0 
25 Sister BANF j (i F 0 NA NA 0 
26 Brother BAN F 26 M 0 NA NA 1 
27 Siste r BA NF 25 F :34 10 0 
Five groups of controls were used; none of these 27 controls had cutaneous 
neurofibromata, ax illary freckles, or iri s Lisch nodules. Eleven had no family 
history of NF and we re either normal vo luntee rs (1 - 9) or the spouse of an NF 
patient (1 0, 11 ). Six we re unaffected parents of YRNF spontaneous mutations 
(12- 17), two were unaffected offs pring of a VH.NF parent (1 8, 19), four were 
parents of BANF sponta neous muta tions (20- 23), and four were unaffected 
sibli ngs of BAN F spontaneous mutations (24 - 27) . T he number of CALM and 
their size is documented as we ll as the number of MM G per 5 high power Jields 
(40X) in the biopsies of the CALM and t.he normal skin. (NA = not applicable 
because no CALM was present; NO = not. done; CALM = cafe-au-lait macule). 
Vol. 85, No. 4 
the number o f MMG/5HPF differed s ignificant ly among the groups of 
patients [1 5]. 
When more t ha n 10 MMG /5 HPF were noted, t he specimen was 
studied by elect ron mic roscopy . The t issue was incubated in a mixture 
of 2.5% gluta raldehyde a nd 2% pa ra formaldehyde solution a t 4•C for 
2-6 h and then postfixed in 2% osmium tetroxide at 4 ·c for 2 h. All 
the f] xa t ives were diluted in 0.1 M cacodyla te buffe r a t pH 7.4. Fixed 
tissues were dehydra ted in a graded e tha nol series, passed t hrough 
propylene oxide, and embedded in Epon 8 12. Ultra thin sections, cut 
seria lly wi t h diamond knives on a Porte r-Blum MT2 microtome, were 
mounted and double-sta ined wi t h ura nyl acetate and lead ci t rate solu-
tions and observed wi t h a Zeiss EM-109 operated at 80 KV. 
RESULTS 
The 27 control subjects (Table I) consisted of 10 males and 
17 females ranging in age from 16- 63 years. None of the 27 
control subjects had cutaneous or plexiform neurofibromata, 
axillary freckles, or iris Lisch nodules. They were divided into 
5 groups. Group A consisted of 9 volunteers and 2 spouses of 
VRNF patients. None of these 11 had a family history of VRNF 
or BANF. Group B contained 6 subjects, each the parent of a 
child with a spontaneous mutation for VRNF. None of these 6 
subjects nor their siblings or parents had any stigmata of NF 
other than the CALM. Group C contained 2 unaffected males, 
each in a different family of VRNF. Group D contained 4 
parents of children with a spontaneous mutation for BANF. 
GroupE contained unaffec ted siblings of patients with a spon-
taneous mutation for BANF. These 4 patients and their parents 
had normal enhanced CT scans, audiograms, and brain stem-
evoked responses. 
Of t he 27 controls, 19 (70%) had at least 1 CALM. Although 
few in number, the CALM in the control group were visually 
indistinguishable in size, configuration, distribution, and degree 
of pigmentation from the CALM in the VRNF group when 
examined both in room light or with a Woods lamp. MMG 
were detected in 9/19 (47 %) CALM in the control group. No 
control had more than 10 MMG/5HPF in a CALM biopsy. 
MMG were found in 5/26 (19 %) biopsies of normal skin in 
controls; none had more than 4 MMG/5HPF. The detection of 
MMG did not correlate with any specific subgroup of the 
controls. 
The 22 patients with VRNF were from 16 different families 
and consisted of 12 males and 10 females (Table II); their ages 
ranged from 16 to 57 years. In biopsies of CALM, MMG were 
TABLE II. M elan£n m.acroglobules (MMC) in von. Recklin.ghausen neurofibromatosis (VRNF) 
Cutaneous Axillary freckles 
MMG 
Case# Age Sex Lisch nodules CALM neurofibromata CALM Normal skin 
1 57 M + + + 6 0 1 
2 16 M + + + 11 0 0 
3 17 F + + + 6 1.2 0 
4 25 M + + + 16 31 0 
5 50 F ++ + + 10 117 0 
6 17 M ++ + + 18 381 213 
7 22 M + + + 5 4 0 
8 5.5 F ++ + + 6 1 6 
9 27 F + + + 10 18 0 
10 26 M +++ + + 6 12 2 
11 22 M +++ + ND 6 85 39 
12 f\4 F ++ + 0 10 77 10 
13 41 F + + + 4 13 1 
14 34 M +++ + 0 6 273 90 
15 23 F + 0 0 7 3 0 
16 31 M +++ + + 6 52 8 
17 29 F + + + 10 26 10 
18 50 M ++++ + + 8 2 1 
1.9 59 F ++ + + 6 2 8 
20 25 M +++ 0 + 8 1070 120 
21 39 F + + N D 10 0 0 
22 20 M + 0 + 12 169 ND 
Cases 1- 10 a re inhe riLed and cases 11- 22 a re new mu ta tions. The number of cutaneous neurofibromata a re graded from 0 to++++, and the 
prese nce or absence of ax illa ry frec kles and iris Li sch nodu les is not.ecl. The number of CALM grea te r tha n 15 mm is noted. The number of 
MM G per 5 high power fi eld in bi ops ies of CALM a nd norm al skin is noted. (ND = not done; CALM = cafe-au-la it macule) . 
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detected in 19/22 (86%); 5/22 (23%) had 1- 10 MMG/5HPF 
while 14/22 (63 %) had 11 or more MMG/5HPF. MMG were 
detected in 13/21 (62%) biopsies of adjacent normal skin; 9/21 
(43%) had 1- 10 MMG/5HPF and 11 or more MMG were seen 
in 4/21 (19%) normal sk in biopsies. One subject did not undergo 
a biopsy of normal skin . 
Of the 22 patients with VRNF, 10 inherited the disorder 
from an affected parent and 12 were t he result of a new 
mutat ion . The CALM biopsies in the inherited group showed 
no MMG in 2/10 (20%), 1- 10 MMG/5HPF in 2/10 (20%), and 
11 or more MMG/5HPF in 6/10 (60%). In the new mutation 
group, 1/ 12 (8%) had no MMG, 3/12 (25 %) had 1- 10 MMG/ 
5HPF, and 8/12 (66%) had 11 or more MMG/5HPF. These 
data show that the mode of acqu isition of VRNF, is not sign if-
icantly related to the number of MMG (p > .3). For the biopsies 
of normal skin in t he inherited VRNF group 6/10 (60%) had 
no MMG , 3/10 (30%) had 1- 10 MMG /5HPF, and 1/10 (10%) 
had 11 or more MMG/5HPF. Adjacent normal skin biopsies 
performed in 11/12 patients in the new mutation VRNF group 
showed that 6/11 (55%) had no MMG, 2/11 (18%) had 1-10 
MMG/5HPF, and 3/11 (27 %) had 11 or more MMG/5HPF. 
BANF was documented in 7 patients (3 males, 4 fema les) 
ranging from 18-46 years of age (Table III). Two of these 
patients inherited t he disorder; the other 5 were spontaneous 
mutations. In a ll cases t he diagnosis of an acoustic neuroma 
was pathologically proven and the bilateral nature of t he tumo rs 
was verified by CT scan. Several of t hese patients had sp inal 
and crania l neurofibromas in addition to the bilatera l acoustic 
neu romas. As previously documented , both CALM and cuta-
neous neurofibromata are infrequent in BANF as compared 
with VRNF [7-9 ]. Also notable is the abse nce of iris Lisch 
nodu les in BANF. CALM were present in 6/7 patients, but 
none had more t han 3 macules. In these biopsies, only 1 had 
detectable MMG and t his spec imen had only 2 MMG/5HPF. 
Normal skin biopsies were obtained in 4 pat ients with BANF; 
none showed MMG. 
The number of MMG/5HPF in the CALM biops ies from 
VRNF patients signifi ca nt ly differed from t he number in 
BANF patients (p < .01) and from the number in t he control 
group (p < .0008). Electron microscopy was performed in 11 of 
t he 14 spec imens showing more than 10 MMG/5HPF and 
confirmed the light microscopic findings (Figs 1, 2). 
DISCUSSION 
Neurofibromatosis (NF) occurs in two distinct forms, clas-
s ical VRNF and BANF [1-3,7- 9]. Both a re transm itted in an 
autosomal dominant fashion wit h high penetrance and with 
variable expression. Both are curre nt ly diagnosed by counting 
a number of clinically or rad iologica lly detected abnormali ties. 
Wh ile enumeration of t hese abno rmali ties is useful for large 
population studies, the variable express ion of t hese clinical 
stigmata often leads to uncertainty when attempting to diag-
nose an individual patient. A biochemical or cellular test spe-
cific for NF would be useful in such instances. Several groups 
F IG 1. Light photomicrograp h (400X) of MMG in a patient with 
VRNF. Open m-rows demonstrate discrete MMG whic h a re uniformly 
dense, spherical, intracellular particles va ry ing in diameter f rom 1- 6 
p.m. The closed arrows demonstrate what wou ld appear to be a clumping 
of p igment but which o n close exami nation is a cluster of discrete 
MMG. 
F IG 2. T his electro n mic rograph (6900X) of a VRNF melanocyte 
demonstrates multiple norma l-sized e ll ipsoid melanosomes which are 
<0.3 ,,m in le ngth (open arrow8) a nd one large sphencal MMG 1.42 
11m in d ia meter (closed arrow). 
TABLE Ill. Melanin macroglobules (MMG) in bilateral acoustic new·ofibrom.at;osis (BANF) 
Cuta neous 
MMG 
Case# Age Sex 
ncuro Jibro mas Axi ll ary freckl es Lisch nodul es CALM Norma l skin CALM 
1 46 F 0 0 0 0 NO 
2 3r. ;) F () 0 0 2 0 NO 
3 22 M + 0 0 2 0 0 
4 18 F 0 0 0 l 0 0 
5 26 M + 0 0 1 2 0 
6 24 F 0 0 0 0 NA 0 
7 28 M ++ 0 0 2 0 NO 
8 35 F 0 0 () 2 0 NO 
Cases l a nd 2 inherited t he diso rder , cases ::l- 7 represe n t new mutations. The presence or absence of cuta neous neurofibromata are noted. 
None of t he patients had ax illa ry freckles o r iri s L isc h nodules. T he number of CALM greate r than 15 mm is recorded a nd the number of MMG 
per 5 high power fi e lds (40X) is documented fo r t he biopsies of CA LM and no rmal skin. (NA = not applicable; 0 =not done; CALM =cafe-
au-la it macule) . 
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have presented data suggesting abnormalit ies of nerve growt h 
facto r in NF patie nts. It has been proposed that the biologic 
activity of nerve growth factor differs in VRNF vs BANF [7, 
16). R icca rdi and Maragos found t hat skin fibroblasts from 
VRNF patients are res istant to t he effects of 3-ni t rotyrosine in 
vit ro when compared to fibroblasts from normal cont rols [10] . 
Neither of these tec hniques has yet been confmned. 
The current study was designed to r:uant ify MMG in the 
CALM and in the normal skin of patients wit h VRNF, patients 
wi th BANF, and in various cont rol groups. The number of 
MMG/5HF in VRNF patients significant ly differed from that 
found in cont rols ( p < .0008). Addit ionally, no normal control 
had more than 10 MMG/5HPF in t heir CALM. In cont rast, 
14/22 (64 %) patients wit h VRNF had more than 10 MMG/ 
5HPF in their CAL M. While MMG could be detected in t he 
normal skin of many VRNF patients, in virtually all cases t he 
numbers were far less than in the CALM, suggesting t hat fu ture 
studies of MMG might be con' ,. ed t o the CALM alone. 
Another findin g of t his study is that of 6 CALM biopsies in 
patients wi t h BANF, only 1 contained 2 MMG/5HPF and the 
other 5 showed no MMG, a findin g significantly different from 
VRNF (p < .01). This may be an addi t ional feat ure distinguish -
ing BANF as a separate ent ity from VRNF. 
T herefore, while the presence or absence of MMG is not 
pathognomonic of NF, quant ification of MMG can different iate 
on a cellular basis t he CALM of VRNF from t he CAL M 
obse rved in BANF and in the normal population. When t he 
diagnosis of VRN F is clea r from clinica l evidence, a biopsy is 
not necessa ry. H owever , biopsy of a CALM and t he documen-
tation of a high density of MMG may potent ia lly prove useful 
in t he patient wi th a family hi story of VRNF but wi t h an 
indete rminate number of clinical stigmata. A high density of 
MM G may suggest VRNF rather t han t he presence of inciden-
tal cafe-au-lait marks. The present study included only patients 
of li ght-skinned racial background who were 16 years or older 
and these data may not apply to patients who a re younge r or 
have darker pigmentation. Moreover, t he usefulness of quan-
t itative MMG analysis will need to be determined in more 
extensive studies searching for t he development of t umors or 
other stigmata over t ime as well as by observing the passage of 
thi s gene to the next generation . Further studies of MMG as a 
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phenotypic marker of cells bearing the NF gene seem warranted 
and may a lso prove useful in gene t ransfer experiments and in 
investigating t he cont rol mechanisms involved in t he expres-
sion of the NF. 
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